“A Randomized, Double-Blind, Placebo-Controlled, Phase 1 2a Trial Protocol to Assess the Safety and Efficacy of TAK-101 Administered by Microneedles in Patients With Celiac Disease”. Principles and Practice of Clinical Research 8, no. 3 (December 21, 2022): 37–48. Accessed July 3, 2024. https://journal.ppcr.org/index.php/ppcrjournal/article/view/185.